Hypertension
Conditions
Brief summary
The purpose of this research study is to test the feasibility, acceptability, and preliminary effectiveness of the use of a mobile pharmacist-led intervention that incorporates home BP monitoring and medication reminders with patients recruited from a primary care setting, as well as identify challenges and potential solutions to broader implementation of a mobile pharmacist-led home-based BP monitoring intervention in primary care clinics through key stakeholder interviews.
Interventions
OTHERBP Track
Sponsors
University of Michigan
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Have a smart phone compatible with mobile intervention * Have been previously diagnosed with hypertension * Have uncontrolled hypertension (systolic blood pressure \> 140 and/or diastolic blood pressure \> 90 on repeat measurement) * Be under the care of a primary care physician at the recruitment clinic * Be taking at least one antihypertensive medication * Be English speaking
Exclusion criteria
* Patients under the care of a clinical pharmacist for hypertension management, or under the care of a cardiologist * Pregnant patients and anyone with the following unrelated, but serious medical conditions will also be excluded, as they may make blood pressure control difficult or necessitate frequent hospitalization: previous diagnosis of resistant hypertension; steroid dependent asthma or emphysema; cirrhosis or hepatic failure; stage C or D chronic heart failure; stage IV or V chronic kidney disease; and cancer (terminal or undergoing active chemotherapeutic or radiation therapy) * Patients with other serious medical conditions (e.g., stroke, dementia) that may affect their ability to self-monitor blood pressure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in blood pressure | from baseline to 12 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Change in medication adherence as measured by the Adherence to Refills and Medications Scale (ARMS) | from baseline to 12 weeks |
Countries
United States
Outcome results
None listed